DIA
MDGL icon

Dana Investment Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Dana Investment Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Buy
3,677
+480
+15% +$246K 0.05% 339
2026
Q1 		$1.67M Buy
3,197
+331
+12% +$158K 0.05% 335
2025
Q4 		$1.67M Sell
2,866
-315
-10% -$161K 0.05% 334
2025
Q3 		$1.46M Buy
3,181
+298
+10% +$111K 0.04% 351
2025
Q2 		$873K Sell
2,883
-70
-2% -$20.9K 0.03% 401
2025
Q1 		$978K Sell
2,953
-1,198
-29% -$394K 0.04% 378
2024
Q4 		$1.28M Buy
4,151
+567
+16% +$159K 0.04% 355
2024
Q3 		$761K Sell
3,584
-129
-3% -$33K 0.03% 412
2024
Q2 		$1.04M Buy
3,713
+438
+13% +$104K 0.04% 369
2024
Q1 		$875K Buy
3,275
+104
+3% +$24.5K 0.03% 385
2023
Q4 		$734K Buy
3,171
+124
+4% +$21.7K 0.04% 285
2023
Q3 		$445K Buy
+3,047
New +$574K 0.02% 324

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dana Investment Advisors's MDGL Position: Q2 2026 in Review

Dana Investment Advisors increased its Madrigal Pharmaceuticals (MDGL) stake by 15% in Q2 2026, buying an estimated $246K and bringing the position to 3,677 shares worth $1.97M. The position accounts for 0.05% of the portfolio, ranked #339.

Dana Investment Advisors first reported a position in MDGL in Q3 2023 and has held it in 12 quarters since. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Dana Investment Advisors held 3,677 shares of Madrigal Pharmaceuticals worth $1.97M as of Q2 2026.
  • Dana Investment Advisors bought 480 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $246K.
  • Madrigal Pharmaceuticals made up 0.05% of Dana Investment Advisors's portfolio in Q2 2026, its #339 holding.
  • Dana Investment Advisors first reported a position in Madrigal Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.